Evidence map›Paper›PMID 28275648›Full record

ArticleStem cell investigation2017

IFN-1 Bid crosstalk: foe or friend to stem cells.

Pratibha Singh, Louis M Pelus

Abstract readEditorialComment
In one paragraph

Article in Stem cell investigation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Pratibha SinghDepartment of Microbiology & Immunology, Indiana University School of Medicine, 950 West Walnut St, R2-302, Indianapolis, IN 46202, USA.
Louis M PelusDepartment of Microbiology & Immunology, Indiana University School of Medicine, 950 West Walnut St, R2-302, Indianapolis, IN 46202, USA.

Funding

Role of PGE2 and other eicosanoids in hematopoietic stem cell functionR01HL096305 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI PELUS, LOUIS M · 2010 to 2018
$3.5M
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cellsR01CA182947 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI FARAG, SHERIF S, PELUS, LOUIS M · 2014 to 2018
$1.6M
A megakaryocyte/PGE2/osteoblast triad in the normal and aged nicheR01AG046246 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI KACENA, MELISSA A, PELUS, LOUIS M · 2013 to 2017
$1.1M
NCI NIH HHS R01 CA182947NHLBI NIH HHS R01 HL096305NIA NIH HHS R01 AG046246
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28275648
PMCPMC5334558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.